Skip to main content
. 2017 Dec 16;9(10):9480–9488. doi: 10.18632/oncotarget.23840

Figure 2. Forest plot for meta-analysis of incidence of all-grade and high-grade ALT elevation in NSCLC patients assigned ALK-TKIs.

Figure 2